- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01479426
A Trial to Evaluate the Efficacy and Safety of EFLA400 Korea Red Ginseng Extract on Sexual Function in Men With Erectile Dysfunction
Efficacy and Safety of EFLA400 Korea Red Ginseng Extract on Erectile Dysfunction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Jeollabuk-do
-
Jeonju, Jeollabuk-do, Korea, Republic of, 560-822
- Clinical Trial Center for Functional Foods; Chonbuk National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aged 17-70 years
- IIEF(International Index of Erectile Function)-5 scores ≤ 21 subjects.
Exclusion Criteria:
- they had other neurologic or psychiatric disorder
- significant hepatic or renal function impairment (hepatic enzymes >1.5 times the upper limit of normal and/or serum creatinine >1.8 mg per 100 ml)
- hypertension (>170/110 mm Hg), hypotension (<90/50 mm Hg) or significant cardiovascular disease (unstable angina, coronary artery disease, myocardial infarction or myocardial revascularization).
- Peyronie's disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: EFLA400(960mg)
|
EFLA400(960mg/day)for 12 weeks
Other Names:
|
Placebo Comparator: Placebo(960mg)
|
Placebo(960mg/day) for 12 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in EF(Erectile Function) Domain
Time Frame: 12 weeks
|
EF(erectile function, score 0-20) domain was measured in study visit 1(0 week) and visit 3(12 week). The original index consists of 4 Questions. Individual question response is assigned a score of between 0 (worst) to 5 (best) and summed to form a score ranging from 0 (worst) to 20 (best). |
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in MSHQ (Male Sexual Health Questionnaire)
Time Frame: 12 weeks
|
MSHQ(Male Sexual Health Questionnaire) was measured in study visit 1(0 week) and visit 3(12 week). The total MSHQ score (25 questions) ranges from 17-130, with higher scores indicating greater sexual function. |
12 weeks
|
GEAQ (Global Efficacy Assessment Question)
Time Frame: after 12weeks of consumption
|
after 12weeks of consumption
|
|
Changes in Uroflowmetry(Max Flow Rate)
Time Frame: 12 weeks
|
uroflowmetry(max flow rate) was measured in study visit 1(0 week) and visit 3(12 week).
|
12 weeks
|
Changes in IIEF(International Index of Erectile Function)-Total Domain
Time Frame: 12 weeks
|
IIEF(International Index of Erectile Function)-total domain(score range: 5-75) was measured in study visit 1(0 week) and visit 3(12 week). IIEF includes 15 questions and addresses the 5 sub-domains of Erectile function, Intercourse satisfaction, Orgasm function, Sexual desire, and Overall satisfaction. The IIEF-total domain is the sum of sub-domains. Lower scores indicate severe erectile dysfunction, while higher scores indicate less erectile dysfunction. |
12 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jong-Kwan Park, MD, Chonbuk National University Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LOTTE-MS-EFLA400
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Subjects(Only Men)
-
University of DelawareWithdrawnno Condition Being Studied; tDCS Only in Healthy SubjectsUnited States
-
University Hospital, Clermont-FerrandService de Biologie de la Reproduction : AMP-CECOS; EA 975, Laboratoire de BDR and other collaboratorsCompletedHealthy Volunteers | Normocholesterolaemic Men | Normozoospermic MenFrance
-
Paulista UniversityRecruiting
-
Heinrich-Heine University, DuesseldorfThe Cranberry InstituteCompleted
-
H. Lundbeck A/SCompleted
-
Yonsei UniversityCompletedHealthy MenKorea, Republic of
-
AstraZenecaCompleted
-
USDA Beltsville Human Nutrition Research CenterCompleted
-
Bio-Thera SolutionsNot yet recruiting
-
Mabscale, LLCActive, not recruitingHealthy MenRussian Federation